University of Michigan, Department of Urologic Oncology
Welcome,         Profile    Billing    Logout  
 7 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Morgan, Todd M
BRIDGE, NCT05538663: Intravesical BCG vs GEMDOCE in NMIBC

Recruiting
3
870
US
Gemcitabine, GEMZAR, Docetaxel, Taxotere, Bacillus Calmette Guerin, BCG
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Non-muscle-invasive Bladder Cancer
11/29
10/30
GUNS, NCT04812366: Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Recruiting
2
315
Canada, US
Apalutamide 60mg Tab, Abiraterone Acetate 250mg, Prednisone 5mg Tab, Docetaxel, Niraparib 100mg Oral Capsule, Atezolizumab
University of British Columbia, Janssen Inc., University Health Network, Toronto
Prostate Cancer
04/26
04/26
BRCAAway, NCT03012321: Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

Active, not recruiting
2
70
US
Olaparib, Lynparza, Abiraterone Acetate, Prednisone
Northwestern University, AstraZeneca, National Cancer Institute (NCI)
Prostate Cancer Metastatic Castration-Resistant, Abnormal DNA Repair, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer
12/26
01/27
G-MINOR, NCT02783950: Genomics in Michigan Impacting Observation or Radiation

Completed
N/A
356
US
Decipher Prostate Cancer Classifier, Decipher Post-Op
University of Michigan Rogel Cancer Center, Michigan Urological Surgery Improvement Collaborative (MUSIC), GenomeDx Biosciences Corp
Prostate Cancer
02/20
04/24
NCT04396808: Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

Recruiting
N/A
900
US
Decipher, Decipher Prostate Cancer Classifier, Prolaris, Prolaris Prostate Cancer Test, Oncotype Dx Genomic Prostate Score (GPS), Standard of care (askMUSIC score), askMUSIC score
University of Michigan Rogel Cancer Center, National Institutes of Health (NIH), Myrexis Inc., Veracyte, Inc., MDx Health
Prostate Cancer
07/25
07/25
PASS, NCT00756665: Prostate Active Surveillance Study

Recruiting
N/A
3000
Canada, US
University of Washington, Canary Foundation, Early Detection Research Network
Prostatic Neoplasms
09/29
09/32
TARGET-HCC, NCT02954094: A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Recruiting
N/A
10000
Europe, US
Target PharmaSolutions, Inc.
Hepatocellular Cancer
10/25
10/25
NCT03692897: An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection

Recruiting
N/A
5000
Canada, US
All approved therapies for the treatment of Chronic Hepatitis B (CHB)
Target PharmaSolutions, Inc.
Hepatitis B, Hepatitis, Liver Diseases
01/26
01/26
Thelen-Perry, Steven
No trials found

Download Options